IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-48915-9.html
   My bibliography  Save this article

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group

Author

Listed:
  • Gilles Freyer

    (Lyon 1 University
    GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut de Cancérologie des HCL)

  • Anne Floquet

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut Bergonié)

  • Olivier Tredan

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Centre Léon Bérard)

  • Aurore Carrot

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    EMR 3738, UFR Lyon-Sud, Université Lyon1)

  • Carole Langlois-Jacques

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Hospices Civils de Lyon)

  • Jonathan Lopez

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Hospices Civils de Lyon)

  • Frédéric Selle

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Groupe Hospitalier Diaconesses Croix Saint-Simon)

  • Cyril Abdeddaim

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Centre Oscar Lambret)

  • Alexandra Leary

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut Gustave Roussy)

  • Coraline Dubot-Poitelon

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut Curie Saint Cloud)

  • Michel Fabbro

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut du Cancer de Montpellier)

  • Laurence Gladieff

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut Claudius Regaud IUCT-Oncopole)

  • Michele Lamuraglia

    (GINECO (Groupe d’Investigateurs Nationaux pour l’Etude des Cancers de l’Ovaire
    Institut de Cancérologie du CHUSE)

Abstract

No abstract is available for this item.

Suggested Citation

  • Gilles Freyer & Anne Floquet & Olivier Tredan & Aurore Carrot & Carole Langlois-Jacques & Jonathan Lopez & Frédéric Selle & Cyril Abdeddaim & Alexandra Leary & Coraline Dubot-Poitelon & Michel Fabbro , 2024. "Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group," Nature Communications, Nature, vol. 15(1), pages 1-1, December.
    • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48915-9
    DOI: 10.1038/s41467-024-48915-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-48915-9
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-48915-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48915-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.